Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Applied Dna Scns (APDN)

Applied Dna Scns (APDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Applied Dna Scns 50 HEALTH SCIENCES DRIVE STONY BROOK NY 11790 USA

www.adnas.com P: 631-840-8800 F: 631-240-8900

Description:

Applied DNA Sciences, Inc. provides proprietary DNA-embedded biotechnology security solutions, using non-human DNA, that verify authenticity and protect corporate and government agencies from counterfeiting, fraud, piracy, product diversion, identity theft and unauthorized intrusion. They develop, market, and sub-license DNA security systems, supply-chain management systems and anti-counterfeit solutions. Applied DNA Sciences has an exclusive licensing and partnership agreement covering North America and Europe with Biowell Technology, Inc. of Taiwan.

Key Statistics

Overview:

Market Capitalization, $K 403
Enterprise Value, $K -6,747
Shares Outstanding, K 985
Annual Sales, $ 13,370 K
Annual Net Income, $ -9,950 K
Last Quarter Sales, $ 930 K
Last Quarter Net Income, $ -4,470 K
EBIT, $ -14,440 K
EBITDA, $ -13,080 K
60-Month Beta 0.08
% of Insider Shareholders 1.00%
% of Institutional Shareholders 22.22%
Float, K 975
% Float 99.00%
Short Volume Ratio 0.45

Growth:

1-Year Return -98.60%
3-Year Return -99.63%
5-Year Return -99.82%
5-Year Revenue Growth 242.82%
5-Year Earnings Growth 95.25%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -5.31 on 05/10/24
Next Earnings Date 08/08/24
Earnings Per Share ttm -17.11
EPS Growth vs. Prev Qtr -195.00%
EPS Growth vs. Prev Year -32.75%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-20 on 04/25/24

APDN Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -306.32%
Return-on-Assets % -101.11%
Profit Margin % -74.42%
Debt/Equity 0.00
Price/Sales 0.03
Price/Cash Flow N/A
Price/Book N/A
Book Value/Share -0.21
Interest Coverage -0.21
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar